Loading
EBR Systems Inc. Stock: price and insider trades · Australia
No insider purchase over the last 90 days. The latest was filed 05 Jul 2026.
EBR Systems Inc.: what insiders have been doing
EBR Systems Inc. belongs to the Healthcare & Pharma sector. Filings by its managers are published through ASX. 2 insiders have disclosed 2 filings since 17 October 2025.
Every open-market trade in the period is a purchase: 1 purchase worth €63k, from 1 insider, and not a single sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. One trade stands out by size: a purchase of €63k from Bronwyn EVANS, disclosed on 5 July 2026. Those buying include 1 senior executive.
For context, the typical company on the same exchange (median of 2,222 companies) published 3 filings over the same period, against 2 filings here. Since 2026, the database holds 1 purchase and no sales by insiders of the company.
The last insider purchase was made public on 5 July 2026, 104 days ago.
For comparison within the same sector, see the insider buying recorded at Anixa Biosciences Inc and Vivos Inc. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.
Insider Decl.
2
Thresholds
n/a
Buy Volume
€63,159
1 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleBronwyn EVANS1 buy
Since the insiders bought
- -65.0%Entry A$0.40 · Close 16 Oct 2026 A$0.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate EBR Systems Inc. Strong Buy (bullish), based on 4 analysts. Average price target: A$1.50.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Fundamental score
Ranked 22,956 of 24,158 companies
15.9
score / 100
Value8
Quality24
FCF yld-30%
Earn yld-25%
EV/EBITDA·
ROE-103%
Gross mgn30%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
A$0.26
Analyst consensus
4 analystsStrong buy
A$0.70Target A$1.50(+487%)A$2.00
Income statement
RevenueA$1.6M
Gross profitA$490k30% margin
EBITDA-A$42.7M-2641% margin
Net income-A$48.8M-3015.3% margin
Valuation
PER (trailing)1.9x
PER (forward)-4.0x
P/Book2.0x
Beta0.52
Balance sheet & cash
Market capA$192.1M
Total debtA$58.6M
Free Cash Flow-A$56.9M
Debt / Equity87%
Profitability & ownership
ROE-102.5%
ROA-28.5%
% insiders0.9%
% institutions38.4%
Last declaration on 5 July 2026
Declarations2 total
275,790 shares@ A$0.38100.0% of flowShareASXISIN AU0000182552ASX:2924-03108025-3A696664
Canonical exit: 27 Sept 2026 (T+90)
42,103 sharesShareASXISIN AU0000182552ASX:2924-03090242-3A693330
2 of 2 declarations
About EBR Systems Inc.
EBR Systems Inc. is a company focused on the healthcare and pharmaceutical sector. It is listed on the XASX market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
